Olayinka I. Arimoro

ORCID: 0009-0009-9464-589X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Ischemic Stroke Management
  • Health Systems, Economic Evaluations, Quality of Life
  • Healthcare Policy and Management
  • Childhood Cancer Survivors' Quality of Life
  • Chronic Disease Management Strategies
  • Pharmacological Effects and Toxicity Studies
  • Stroke Rehabilitation and Recovery
  • Bipolar Disorder and Treatment
  • Venous Thromboembolism Diagnosis and Management
  • Child and Adolescent Psychosocial and Emotional Development
  • Geriatric Care and Nursing Homes
  • Emergency and Acute Care Studies
  • Epilepsy research and treatment
  • Pharmaceutical studies and practices
  • Healthcare Systems and Practices
  • Infant Development and Preterm Care

University of Calgary
2023-2024

Alberta Health Services
2023

BACKGROUND: Recent evidence from thrombolysis trials indicates the noninferiority of intravenous tenecteplase to alteplase with respect good functional outcomes in patients acute stroke. We examined whether health-related quality life (HRQOL) stroke differs by type treatment received. In addition, we association between modified Rankin Scale score 0 1 and HRQOL patient-reported return prebaseline functioning at 90 days. METHODS: Data were all included AcT trial (Alteplase Compared...

10.1161/strokeaha.123.044690 article EN Stroke 2024-01-26

Abstract Background A substantial proportion of children have a physical illness; these commonly experience physical–mental comorbidity. To assess child mental health, brief scales that can be used in clinical and research settings are needed. This study assessed the validity reliability parent‐reported Ontario Child Health Study Emotional Behavioural Scale‐Brief Version (OCHS‐EBS‐B) scores. Methods Data come from longitudinal aged 2–16 years with illness recruited outpatient clinics at...

10.1111/cch.13300 article EN cc-by-nc-nd Child Care Health and Development 2024-07-01

Abstract Objective Health state utilities are required to obtain quality adjusted life years, a common metric that informs clinical decision‐making at individual, group, and health policy levels. different from health‐related of life, their distribution across patients with epilepsy, as well the factors impact them, have not been studied in depth. We aimed describe people epilepsy combinations demographic on evaluation. Methods performed retrospective analysis patients' data prospectively...

10.1111/epi.18132 article EN cc-by-nc-nd Epilepsia 2024-10-07

Introduction: Utility-weighted mRS (UW-mRS) is increasingly being adopted as an important clinical endpoint in stroke trials it offers some gains statistical efficiency and power when estimating treatment effects. The widely used utility weights for UW-mRS, derived from a systematic review of acute trials, are prone to substantial variability across between categories. This study aims derive UW-mRS by directly mapping 5-item EuroQoL (EQ-5D-5L) responses scores. Methods: Data were collected...

10.1161/str.55.suppl_1.wp13 article EN Stroke 2024-02-01

Background and aims: Recent evidence from thrombolysis trials indicate the non-inferiority of Tenecteplase (TNK) to Alteplase (TPA) with respect functional outcomes in acute stroke patients. This study examines predictors patient-reported health-related quality life (HRQOL) patients who received therapy. Methods: Data were used all included AcT, a pragmatic, registry-linked randomized trial comparing TNK TPA. HRQOL at 90-day post-randomization was assessed using EuroQol-5D-5L (EQ-5D) visual...

10.1161/str.54.suppl_1.wmp11 article EN Stroke 2023-02-01
Coming Soon ...